Skip to main content

Publications

Arredondo Zamarripa, D, Noguez Imm, R, Bautista Cortés, AM, Vázquez Ruíz, O, Bernardini, M, Fiorio Pla, A, Gkika, D, Prevarskaya, N, López-Casillas, F, Liedtke, W, Clapp, C, and Thébault, S. "Dual contribution of TRPV4 antagonism in the regulatory effect of vasoinhibins on blood-retinal barrier permeability: diabetic milieu makes a difference." Scientific Reports 7, no. 1 (December 2017).

Full Text

Davis, SW, Luber, B, Murphy, DLK, Lisanby, SH, and Cabeza, R. "Frequency-specific neuromodulation of local and distant connectivity in aging and episodic memory function." Human brain mapping 38, no. 12 (December 2017): 5987-6004.

Full Text

Smith, EE, Saver, JL, Cox, M, Liang, L, Matsouaka, R, Xian, Y, Bhatt, DL, Fonarow, GC, and Schwamm, LH. "Increase in Endovascular Therapy in Get With The Guidelines-Stroke After the Publication of Pivotal Trials." Circulation 136, no. 24 (December 2017): 2303-2310.

Full Text

Yu, L, Lutz, MW, Farfel, JM, Wilson, RS, Burns, DK, Saunders, AM, De Jager, PL, Barnes, LL, Schneider, JA, and Bennett, DA. "Neuropathologic features of TOMM40 '523 variant on late-life cognitive decline." Alzheimer's & dementia : the journal of the Alzheimer's Association 13, no. 12 (December 2017): 1380-1388.

Full Text

Dickey, AS, Sanchez, DN, Arreola, M, Sampat, KR, Fan, W, Arbez, N, Akimov, S, Van Kanegan, MJ, Ohnishi, K, Gilmore-Hall, SK, Flores, AL, Nguyen, JM, Lomas, N, Hsu, CL, Lo, DC, Ross, CA, Masliah, E, Evans, RM, and La Spada, AR. "PPARδ activation by bexarotene promotes neuroprotection by restoring bioenergetic and quality control homeostasis." Science translational medicine 9, no. 419 (December 2017).

Full Text

Howard, JF, Utsugisawa, K, Benatar, M, Murai, H, Barohn, RJ, Illa, I, Jacob, S, Vissing, J, Burns, TM, Kissel, JT, Muppidi, S, Nowak, RJ, O'Brien, F, Wang, J-J, Mantegazza, R, and REGAIN Study Group, . "Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study." The Lancet. Neurology 16, no. 12 (December 2017): 976-986.

Full Text

Gaist, D, Goldstein, LB, Cea Soriano, L, and García Rodríguez, LA. "Statins and the Risk of Intracerebral Hemorrhage in Patients With Previous Ischemic Stroke or Transient Ischemic Attack." Stroke 48, no. 12 (December 2017): 3245-3251.

Full Text

Earl, DE, Loochtan, AI, and Bedlack, RS. "Refractory myasthenia gravis exacerbation triggered By pembrolizumab." Muscle & nerve (November 28, 2017).

Full Text

Howlett, EH, Jensen, N, Belmonte, F, Zafar, F, Hu, X, Kluss, J, Schüle, B, Kaufman, BA, Greenamyre, JT, and Sanders, LH. "LRRK2 G2019S-induced mitochondrial DNA damage is LRRK2 kinase dependent and inhibition restores mtDNA integrity in Parkinson’s disease." Human Molecular Genetics 26, no. 22 (November 15, 2017): 4340-4351.

Full Text

Ghiaseddin, A, Reardon, D, Massey, W, Mannerino, A, Lipp, ES, Herndon, JE, McSherry, F, Desjardins, A, Randazzo, D, Friedman, HS, and Peters, KB. "Phase II Study of Bevacizumab and Vorinostat for Patients with Recurrent World Health Organization Grade 4 Malignant Glioma." The oncologist (November 13, 2017).

Full Text

Pages